| Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. (NCT04753879) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-09-29 |
| Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain (NCT05995912) | Laboratorios Liomont | 2021-09-29 |
| A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT05241106) | Tarapeutics Science Inc. | 2021-09-29 |
| Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma (NCT04941274) | National Cancer Institute (NCI) | 2021-09-29 |
| TEIPP Immunotherapy in Patients With NSCLC (NCT05898763) | Erasmus Medical Center | 2021-09-29 |
| NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF) (NCT05005845) | NFlection Therapeutics, Inc. | 2021-09-29 |
| Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings (NCT04969601) | Assistance Publique - Hôpitaux de Paris | 2021-09-29 |
| Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors (NCT04290897) | Jonsson Comprehensive Cancer Center | 2021-09-29 |
| Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis (NCT04857112) | Bausch Health Americas, Inc. | 2021-09-29 |
| Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (NCT04975919) | M.D. Anderson Cancer Center | 2021-09-29 |
| Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness (NCT05298813) | Immune Biosolutions Inc | 2021-09-29 |
| Microbiome and Association With Implant Infections (NCT05020574) | University of California, San Francisco | 2021-09-28 |
| Dose Finding for Intraoperative Photodynamic Therapy of Glioblastoma (NCT04391062) | University Hospital, Lille | 2021-09-28 |
| Higher Dose of Rekovelle in Oocyte Donors (NCT04778358) | IVI Madrid | 2021-09-28 |
| Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer (NCT04940286) | M.D. Anderson Cancer Center | 2021-09-28 |
| Nab-Paclitaxel in Combination With Nivolumab to Treat Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma That Progressed on a PD-1 or PD-L1 Inhibitor (NCT04831320) | Washington University School of Medicine | 2021-09-28 |
| A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004) (NCT05005442) | Merck Sharp & Dohme LLC | 2021-09-28 |
| A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer (NCT04931654) | AstraZeneca | 2021-09-28 |
| Stereotactic Ablative Radiotherapy for Oligometastatic Hepatocellular Carcinoma (NCT05173610) | Yonsei University | 2021-09-28 |
| Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer (NCT05161572) | Fudan University | 2021-09-28 |
| Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia (NCT04998201) | Arrowhead Pharmaceuticals | 2021-09-28 |
| Anlotinib Capsules in the Treatment for IPF/PF-ILDs (NCT05828953) | First Affiliated Hospital of Wenzhou Medical University | 2021-09-28 |
| Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53) (NCT04906460) | Wave Life Sciences USA, Inc. | 2021-09-28 |
| Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer (NCT04984733) | University of Southampton | 2021-09-28 |
| CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II (NCT04516993) | Huashan Hospital | 2021-09-28 |
| 68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer (NCT04716725) | Thomas Hope | 2021-09-28 |
| A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis (NCT04875975) | UCB Biopharma SRL | 2021-09-27 |
| A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive (NCT05007080) | Janssen Vaccines & Prevention B.V. | 2021-09-27 |
| A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules (NCT06076681) | TenNor Therapeutics (Suzhou) Limited | 2021-09-27 |
| Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites. (NCT04577066) | Leiden University Medical Center | 2021-09-27 |
| Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 (NCT04830124) | Mural Oncology, Inc | 2021-09-27 |
| Qbrexza Cloths for Hyperhidrosis of Amputation Sites (NCT04924036) | University of Utah | 2021-09-27 |
| SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer (NCT04977024) | GeoVax, Inc. | 2021-09-27 |
| A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant Neoplasm (NCT05048160) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-09-27 |
| Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases (NCT04728633) | Thomas Jefferson University | 2021-09-27 |
| Primary Tumor Resection With EGFR TKI for Stage IV NSCLC (NCT05215548) | National Taiwan University Hospital | 2021-09-27 |
| A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease (NCT04884815) | Ultragenyx Pharmaceutical Inc | 2021-09-27 |
| Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular Carcinoma (NCT05057845) | Fudan University | 2021-09-26 |
| Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological Malignancies (NCT05051696) | Liu Zi | 2021-09-26 |
| Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis (NCT05057052) | Fudan University | 2021-09-26 |
| Machine Learning Sepsis Alert Notification Using Clinical Data (NCT04005001) | Dascena | 2021-09-25 |
| Efficacy of PJS-539 for Adult Patients With COVID-19. (NCT05008393) | Hospital do Coracao | 2021-09-25 |
| Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine (NCT05049226) | Mahidol University | 2021-09-24 |
| Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis (NCT04767984) | Northwestern University | 2021-09-24 |
| Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) (NCT04928222) | SkinJect, Inc. | 2021-09-24 |
| Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors (NCT04930432) | Betta Pharmaceuticals Co., Ltd. | 2021-09-24 |
| Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD (NCT04882124) | Novartis Pharmaceuticals | 2021-09-24 |
| Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases (NCT04837885) | University Hospital, Bordeaux | 2021-09-24 |
| Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC (NCT04765709) | Mario Negri Institute for Pharmacological Research | 2021-09-24 |
| Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation (NCT04679012) | Weill Medical College of Cornell University | 2021-09-24 |
| A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma (NCT04003896) | Milton S. Hershey Medical Center | 2021-09-24 |
| Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (NCT04799288) | National Institute of Neurological Disorders and Stroke (NINDS) | 2021-09-24 |
| Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI (NCT04812431) | S.Biomedics Co., Ltd. | 2021-09-23 |
| Study of INBRX-109 in Conventional Chondrosarcoma (NCT04950075) | Inhibrx Biosciences, Inc | 2021-09-23 |
| ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo (NCT05070260) | Acticor Biotech | 2021-09-23 |
| Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299) | M.D. Anderson Cancer Center | 2021-09-23 |
| Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction (NCT04703842) | Sardocor Corp. | 2021-09-23 |
| A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) (NCT04914897) | Sanofi | 2021-09-23 |
| Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies (NCT04959175) | National Cancer Institute (NCI) | 2021-09-23 |
| A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors (NCT05071183) | Turning Point Therapeutics, Inc. | 2021-09-23 |
| A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis (NCT05003531) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-09-23 |
| TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study (NCT04796025) | Sun Yat-sen University | 2021-09-23 |
| Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer (NCT04720664) | Georgetown University | 2021-09-22 |
| Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) (NCT04991103) | University of Alabama at Birmingham | 2021-09-22 |
| A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma Multiforme (NCT05053880) | Accendatech USA Inc. | 2021-09-22 |
| An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome (NCT04988867) | ACADIA Pharmaceuticals Inc. | 2021-09-22 |
| 68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy (NCT05000372) | Peking University Cancer Hospital & Institute | 2021-09-22 |
| A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors (NCT05116891) | Cantargia AB | 2021-09-22 |
| Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement (NCT04221438) | ECOG-ACRIN Cancer Research Group | 2021-09-22 |
| Abatacept Conversion in Kidney Transplantation (NCT04955366) | Emory University | 2021-09-22 |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (NCT05050136) | Mirum Pharmaceuticals, Inc. | 2021-09-22 |
| Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) (NCT05469659) | Shinshu University | 2021-09-22 |
| VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa (NCT04772547) | University of Florida | 2021-09-22 |
| A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease (NCT05015127) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-09-22 |
| Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) (NCT04919239) | Archivel Farma S.L. | 2021-09-22 |
| Sitravatinib in Metastatic Breast Cancer (NCT04123704) | Xiang Zhang | 2021-09-22 |
| FLuticasone in cOvid Treatment (FLOT) (NCT05054322) | University of Medicine and Pharmacy at Ho Chi Minh City | 2021-09-22 |
| Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma (NCT04561492) | Nantes University Hospital | 2021-09-21 |
| ARID1A and/or KDM6A Mutation and CXCL13 Expression (NCT04953104) | M.D. Anderson Cancer Center | 2021-09-21 |
| Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases (NCT04723069) | University of Karachi | 2021-09-21 |
| A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS) (NCT04968912) | Janssen Research & Development, LLC | 2021-09-21 |
| Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (NCT04710628) | MedSIR | 2021-09-21 |
| Nivolumab for the Treatment of Metastatic or Unresectable Solid Tumors With ARID1A Mutation and CXCL13 Expression (NCT04957615) | M.D. Anderson Cancer Center | 2021-09-21 |
| A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 (NCT04945226) | Inventage Lab., Inc. | 2021-09-21 |
| Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (NCT04812366) | University of British Columbia | 2021-09-21 |
| Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer (NCT04758780) | Institut Cancerologie de l'Ouest | 2021-09-21 |
| Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (NCT05088057) | Aiping Shi | 2021-09-20 |
| Study of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS) (NCT04868968) | Novartis Pharmaceuticals | 2021-09-20 |
| Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX) (NCT05082688) | Radboud University Medical Center | 2021-09-20 |
| Liver Directed RT + Chemo-immunotherapy for ES-SCLC (NCT04923776) | Brian Henick, MD | 2021-09-20 |
| Efficacy and Safety Study of Multiple Doses of VIT-2763 in Adults With Transfusion-dependent Beta-thalassemia (NCT04938635) | Vifor (International) Inc. | 2021-09-20 |
| A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain (NCT04976738) | Cymra Life Sciences | 2021-09-20 |
| Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection. (NCT05007236) | Rhizen Pharmaceuticals SA | 2021-09-20 |
| Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis (NCT04886258) | Novartis Pharmaceuticals | 2021-09-20 |
| SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease (NCT04896606) | New York Medical College | 2021-09-20 |
| Evaluation of FDY-5301 in Major Trauma Patients in ICU (NCT04430283) | Faraday Pharmaceuticals, Inc. | 2021-09-20 |
| A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma (NCT05077280) | California Pacific Medical Center Research Institute | 2021-09-20 |
| Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer (NCT05095207) | Icahn School of Medicine at Mount Sinai | 2021-09-20 |
| Acceleration of Orthodontic Tooth Movement (NCT05560919) | Latakia University | 2021-09-20 |
| A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors (NCT04826341) | National Cancer Institute (NCI) | 2021-09-20 |